← FDA DRUG APPROVALS

FDA ANDA · ANDA084710

OGEN

Sponsor: PHARMACIA AND UPJOHN

APPLICATION
ANDA084710
TYPE
ANDA
ORIGINAL APPROVAL
1977-06-03
LATEST ACTION
2015-11-03
ROUTE
VAGINAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

OGENDiscontinued
ESTROPIPATE 1.5MG/GM · CREAM · VAGINAL

Approval history

2015-11-03Labeling · Supplement 22AP
1998-04-01Manufacturing (CMC) · Supplement 20AP
1996-09-24Manufacturing (CMC) · Supplement 19AP
1994-02-16Labeling · Supplement 18AP
1991-04-02Manufacturing (CMC) · Supplement 16AP
1991-04-02Manufacturing (CMC) · Supplement 17AP
1987-08-17Manufacturing (CMC) · Supplement 12AP
1984-01-03Manufacturing (CMC) · Supplement 10AP
1977-06-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →